secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2024-05-06T23:59:59+00:00
Accession:  0000885725-24-000048
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific shareholders approve bylaw amendments and elect directors at annual meeting
--------------------------------------------------------------------------------

- All nine director nominees elected with votes ranging from 1.17B to 1.25B in favor.
- Amendment to bylaws approved (1.24B for, 6.55M against); updates advance notice period to 90-120 days and universal proxy rule compliance.
- Say-on-pay non-binding advisory vote approved: 1.16B for, 90.95M against.
- Ratification of Ernst & Young as auditor for 2024: 1.22B for, 105.62M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572524000048/0000885725-24-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572524000048/bsx-20240502.htm
  HTML page:      https://secwatch.observer/filing/0000885725-24-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer